Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Recruiting 2Terminated 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1CNS 1

Conditions

Colonic Neoplasms 3Adenoma 2Venous Thromboembolism 1Urinary Bladder Neoplasms 1Thrombocytopenia 1Soft Tissue Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Node Positive HER2 Negative Breast Cancer 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myocardial Infarction 1Multiple Myeloma 1Hereditary Sensory and Autonomic Neuropathies 1Hematuria 1Hematologic Diseases 1Glioblastoma 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Breast Neoplasms 1Adenomatous Polyps 1Adenocarcinoma of Lung 1Acute Coronary Syndrome 1

Interventions

Dalteparin 5Tinzaparin 4apixaban 2abelacimab 2Nadroparin 2MAA868 2Heparin, Low-Molecular-Weight 2Enoxaparin 2reviparin 1certoparin 1bemiparin 1acarboxyprothrombin 1Warfarin 1Rivaroxaban 1Platelet Transfusion 1Phenprocoumon 1Mass Screening 1Hematologic Tests 1Aspirin 1Acenocoumarol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Venous Thromboembolism × Aspirin × Clear all
NCT00790452 2011-12-08

Aspirin Prophylaxis for Venous Thromboembolism in Glioblastoma

M.D. Anderson Cancer Center

Phase 2 Terminated
1 enrolled 1 chart
CNSClassical hematology

Glioblastoma, Hematologic Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡